Genistein, Resveratrol, and 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Induce Cytochrome P450 4F2 Expression through an AMP-Activated Protein Kinase-Dependent Pathway
暂无分享,去创建一个
[1] Steven N. Hart,et al. A Comparison of Whole Genome Gene Expression Profiles of HepaRG Cells and HepG2 Cells to Primary Human Hepatocytes and Human Liver Tissues , 2010, Drug Metabolism and Disposition.
[2] J. Auwerx,et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. , 2010, Cell metabolism.
[3] D. Hardie,et al. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. , 2010, Biochimica et biophysica acta.
[4] M. Rieder,et al. CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant , 2009, Molecular Pharmacology.
[5] J. Corral,et al. Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. , 2009, Blood.
[6] B. Viollet,et al. AMP‐activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives , 2009, Acta physiologica.
[7] R. Tukey,et al. Opposing Roles of Peroxisome Proliferator-activated Receptor α and Growth Hormone in the Regulation of CYP4A11 Expression in a Transgenic Mouse Model* , 2009, The Journal of Biological Chemistry.
[8] T. Nakayama,et al. A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men. , 2009, Molecular genetics and metabolism.
[9] T. Nakayama,et al. A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men. , 2008, American journal of hypertension.
[10] R. Magnusson,et al. Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. , 2008, Archives of biochemistry and biophysics.
[11] G. Lippi,et al. The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure , 2008, Hypertension.
[12] G. Labbe,et al. Drug‐induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies , 2008, Fundamental & clinical pharmacology.
[13] Fan Lan,et al. SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase* , 2008, Journal of Biological Chemistry.
[14] J. Hardwick. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. , 2008, Biochemical pharmacology.
[15] J. Hodgson,et al. A Single Nucleotide Polymorphism in the CYP4F2 but not CYP4A11 Gene Is Associated With Increased 20-HETE Excretion and Blood Pressure , 2008, Hypertension.
[16] Y. Turpaz,et al. CYP4F2 genetic variant alters required warfarin dose. , 2008, Blood.
[17] R. Magnusson,et al. Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11 Published, JLR Papers in Press, December 7, 2007. , 2008, Journal of Lipid Research.
[18] In-kyu Lee,et al. Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP , 2008, Diabetes.
[19] B. Viollet,et al. Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase* , 2007, Journal of Biological Chemistry.
[20] M. Rieder,et al. Functional polymorphism in human CYP4F2 decreases 20-HETE production. , 2007, Physiological genomics.
[21] Eric F. Johnson,et al. Regulation of Human Cytochrome P450 4F2 Expression by Sterol Regulatory Element-binding Protein and Lovastatin* , 2007, Journal of Biological Chemistry.
[22] Eric F. Johnson,et al. Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation , 2007, Drug metabolism reviews.
[23] B. Viollet,et al. Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver , 2006, Molecular Pharmacology.
[24] C. Huard,et al. Inhibition of Gluconeogenesis through Transcriptional Activation of EGR1 and DUSP4 by AMP-activated Kinase* , 2006, Journal of Biological Chemistry.
[25] R. Wanders,et al. Identification of the cytochrome P450 enzymes responsible for the ω‐hydroxylation of phytanic acid , 2006, FEBS letters.
[26] R. Wanders,et al. Omega-oxidation of very long-chain fatty acids in human liver microsomes. Implications for X-linked adrenoleukodystrophy. , 2006, The Journal of biological chemistry.
[27] J. Ha,et al. Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. , 2005, Biochemical and biophysical research communications.
[28] R. Roman,et al. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. , 2005, Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi.
[29] T. Osborne,et al. Soy Isoflavones Affect Sterol Regulatory Element Binding Proteins (SREBPs) and SREBP-Regulated Genes in HepG2 Cells 1,2 , 2004 .
[30] Yu Hong,et al. AMP-activated Protein Kinase Regulates HNF4α Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability* , 2003, Journal of Biological Chemistry.
[31] Hitoshi Shimano,et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes DOI 10.1194/jlr.M100417-JLR200 , 2002, Journal of Lipid Research.
[32] H. Yamashita,et al. Mechanism for Fatty Acid “Sparing” Effect on Glucose-induced Transcription , 2002, The Journal of Biological Chemistry.
[33] D. Gottschling,et al. Identification of a small molecule inhibitor of Sir2p , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Falck,et al. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. , 2001, Biochemical and biophysical research communications.
[35] T. Leff. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. , 2001, Biochemical Society transactions.
[36] P. Wilson,et al. Formation of 20-Hydroxyeicosatetraenoic Acid, a Vasoactive and Natriuretic Eicosanoid, in Human Kidney , 2000, The Journal of Biological Chemistry.
[37] M. Vincent,et al. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP‐activated protein kinase , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] C. Lang,et al. Sepsis and AMPK Activation by AICAR Differentially Regulate FoxO-1, -3 and -4 mRNA in Striated Muscle. , 2008, International journal of clinical and experimental medicine.
[39] J. Reddy,et al. Peroxisomal lipid metabolism. , 1994, Annual review of nutrition.